Lumexa Imaging (LMRI) Stock Price, News & Analysis

Company Overview

Lumexa Imaging, Inc. (NASDAQ: LMRI) is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company’s imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc. and adopted the Lumexa Imaging name as part of its corporate rebranding. The company serves patients across multiple U.S. markets, with a focus on providing convenient, non-hospital alternatives for diagnostic imaging. Information about its current leadership and detailed geographic footprint was not included because reliable, current details were not available.

Key Stats

• Today's Range: $9.98 to $10.25
• 50-Day Range: $9.88 to $12.42
• 52-Week Range: $6.45 to $19.45
• Volume: 26,119 shs
• Average Volume: 728,381 shs
• Market Capitalization: $983.76 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $17.50
• Consensus Rating: Moderate Buy

Lumexa Imaging Stock Analysis - MarketRank™

Lumexa Imaging scored higher than 86% of companies evaluated by MarketBeat, and ranked 96th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Buy

Consensus Rating

Lumexa Imaging has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Lumexa Imaging has a consensus price target of $16.00, representing about 56.3% upside from its current price of $10.24.

Amount of Analyst Coverage

Lumexa Imaging has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 160.00%

Earnings Growth

Earnings for Lumexa Imaging are expected to grow by 160.00% in the coming year, from $0.25 to $0.65 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Lumexa Imaging is -20.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Lumexa Imaging is -20.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Lumexa Imaging has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.23% of the float of Lumexa Imaging has been sold short.

Short Interest Ratio / Days to Cover

Lumexa Imaging has a short interest ratio ("days to cover") of 7.33.

Change versus previous month

Short interest in Lumexa Imaging has recently decreased by 18.45%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Lumexa Imaging does not currently pay a dividend.

Dividend Growth

Lumexa Imaging does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.73

News Sentiment

Lumexa Imaging has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Lumexa Imaging this week, compared to 1 article on an average week.

Search Interest

2 people have searched for LMRI on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Lumexa Imaging to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Lumexa Imaging insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.70% of the stock of Lumexa Imaging is held by insiders.

Percentage Held by Institutions

Lumexa Imaging has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:LMRI
• CIK: 2071288
• Web: www.lumexaimaging.com
• Phone: (704) 334-7830
• Fax: N/A
• Employees: 5,019
• Year Founded: 2025

Price Target and Rating

• Average Price Target for Lumexa Imaging: $16.00
• High Price Target: $18.00
• Low Price Target: $13.00
• Potential Upside/Downside: +56.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 40.96
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.40
• Current Ratio: 1.44
• Quick Ratio: 1.44

Sales & Book Value

• Annual Sales: $267.73 million
• Price / Sales: 3.67
• Cash Flow: $0.35 per share
• Price / Cash Flow: 29.37
• Book Value: $6.20 per share
• Price / Book: 1.65

Miscellaneous

• Outstanding Shares: 96,070,000
• Free Float: 95,402,000
• Market Cap: $983.76 million
• Optionable: N/A
• Beta: N/A